# Methylprednisolone N Acetylcysteine in Hepatic Resections

> **NCT01726465** · PHASE2 · TERMINATED · sponsor: **Istituto Clinico Humanitas** · enrollment: 50 (actual)

## Conditions studied

- Ischemic Reperfusion Injury
- Insufficiency; Hepatic, Postoperative
- Liver Tumour

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT01726465
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** The first phase was completed
- **Last updated:** 2013-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01726465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01726465, "Methylprednisolone N Acetylcysteine in Hepatic Resections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01726465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*